Connor, Clark & Lunn Investment Management (CC&L)
MURA

Connor, Clark & Lunn Investment Management (CC&L)’s Mural Oncology MURA Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio MURA Stock Details MURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-47,921
Closed -$234K – 1573
2024
Q1 		$234K Sell
47,921
-3,241
-6% -$15.7K ﹤0.01% 1355
2023
Q4 		$303K Buy
+51,162
New +$206K ﹤0.01% 1172

Other funds holding MURA

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $265M AUM 98.61% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s MURA Position: Q2 2024 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Mural Oncology (MURA) in Q2 2024, closing a stake of 47,921 shares — an estimated $234K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in MURA in Q4 2023 and held it in 2 quarters. The position peaked at $303K in Q4 2023. 86 funds tracked by Wall St. Rank hold MURA as of Q2 2024.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Mural Oncology position as of Q2 2024 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 47,921 Mural Oncology shares in Q2 2024, an estimated $234K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Mural Oncology in Q4 2023 and held it in 2 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Mural Oncology position peaked at $303K in Q4 2023.
  • 86 funds tracked by Wall St. Rank held Mural Oncology as of Q2 2024.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2024, filed 9 Aug 2024.